Vericel Corporation (VCEL)

33,50 -0,50 (-1,47%) Börsenschluss: 04:00PM EDT

Vericel Corporation

64 Sidney Street
Cambridge, MA 02139
United States
617 588 5555
https://vcel.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 305

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Dominick C. Colangelo Esq.	CEO, Pres & Director	1,42M	N/A	1964
Mr. Joseph Anthony Mara Jr.	CFO & Treasurer	673,44k	N/A	1976
Mr. Michael Halpin	Chief Operating Officer	718,24k	N/A	1961
Mr. Sean C. Flynn	Sr. VP, Gen. Counsel & Sec.	593,24k	N/A	1974
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.	Chief Medical Officer	615,24k	523,7k	1962
Mr. Jonathan Siegal	Principal Accounting Officer, VP & Corp. Controller	N/A	N/A	N/A
Mr. Eric Burns	VP of Fin. & Investor Relations	N/A	N/A	N/A
Mr. Patrick J. Fowler	Sr. VP of Corp. Devel. & Strategy	N/A	N/A	N/A
Mr. Patrick Helfrich	VP of Marketing & Commercial Strategy	N/A	N/A	N/A
Ms. Heidi Hassen	Sr. VP of HR	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Vericel Corporations ISS Governance QualityScore, Stand 1. September 2023, lautet 4. Die grundlegenden Scores sind Audit: 6, Vorstand: 3, Shareholderrechte: 4, Kompensation: 5.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.